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Edited by Ivan SadowskiAbstract Receptor-like protein tyrosine phosphatases (RPTPs)
are type I integral membrane proteins. Together with protein
tyrosine kinases, RPTPs regulate the phosphotyrosine levels in
the cell. Studies of two RPTPs, CD45 and PTPa, have provided
strong evidence that dimerization leads to inactivation of the
receptors, and that the dimerization of PTPa involves interac-
tions in the transmembrane domain (TMD). Using the TOX-
CAT assay, a genetic approach for analyzing TM interactions
in Escherichia coli membranes, we show that the TMD of
RPTPs interact in the membrane, albeit to diﬀerent extents.
Using fusion proteins of TMDs, we also observe an equilibrium
between monomer and dimer in sodium dodecyl sulfate (SDS)
micelles. Through a mutational study of the DEP1 TMD, we
demonstrate that these interactions are speciﬁc. Taken together,
our results deﬁne a subset of the RPTP family in which TM
homodimerization may act as a mediator of protein function.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Protein tyrosine phosphatases (PTPs) and protein tyrosine
kinases (PTKs) exert their inﬂuences on signal transduction
by regulating phosphorylation of tyrosines in proteins. The
membrane-bound receptor-like PTPs (RPTPs) have an extra-
cellular domain, a single transmembrane domain (TMD),
and either one or two cytosolic phosphatase domains [1].
Structural studies have raised the debate about whether and
how RPTPs dimerize [2], but nevertheless biochemical studies
of CD45 and PTPa indicated that RPTP function may be
downregulated by receptor dimerization [3,4]. In addition, it
was found that the TMD of PTPa is necessary and suﬃcient
for mediating receptor dimerization [5–8].
A step toward understanding the contribution of the TMD
to RPTP dimerization is to isolate it from the extra- and intra-
cellular domains. Here, we take this approach in studying TM
dimerization of the RPTP family using the TOXCAT system
[9–11]. TOXCAT is a genetic system that allows identiﬁcation*Corresponding author. Fax: +1 203 436 4369.
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doi:10.1016/j.febslet.2005.05.071and quantitative analysis of TM oligomerization. We show
that TM dimerization is a clear feature of the RPTPs with
one exception, and that the interaction is quite strong in sev-
eral cases. In addition, using staphylococcal nuclease (SN) fu-
sion proteins of TMDs of CD45, PTPk, PTPa, PTPc, PTPb,
DEP1 and GLEPP1, we observe an equilibrium between
monomer and dimer in sodium dodecyl sulfate (SDS) micelles.
Our results indicate that TMDs may contribute to the homo-
dimerization of several RPTPs. We also demonstrate that, in
the case of DEP1, TM interactions can be enhanced or dimin-
ished by single site mutations. Such sensitivity suggests the
existence of a speciﬁc packing interface optimized for TM
dimerization.2. Materials and methods
2.1. DNA construction
Oligonucleotides encoding the TMD of each construct were ampli-
ﬁed by PCR and cloned into NheI and BamHI sites of the expression
vector pccKAN as described previously [9]. The SN fusion protein con-
structs were made based on a modiﬁed pET14b expression vector (gift
from Albert Lee). Site-directed mutagenesis was carried out using
QuikChange (Stratagene, La Jolla, CA).
2.2. TOXCAT assay
NT326 (an MBP deﬁcient Escherichia coli strain) was used as a host
strain for the TOXCAT assay. An MBP complementarity assay was
carried out to test the membrane topology of the constructs as de-
scribed previously [9]. Constructs expressed in NT326 were cultured
on M9 agar plates with 0.4% maltose as the only carbon source. The
CAT assay was performed as previously described [12]. Brieﬂy, cell ly-
sates were made by resuspending cell pellets in 500 ll of 0.1 M Tris, pH
8 containing 20 ll of 100 mM EDTA, 100 mM dithiothreitol and
50 mM Tris, pH 8, and one drop of toluene and incubated at 30 C
for 30 min. The cell lysates were then diluted 1:50 before being used
in the CAT assay. Samples were incubated at 37 C for 90 min with tri-
tiated chloramphenicol and n-butyryl coenzyme A. The reaction was
stopped by adding xylene to extract the [3H] chloramphenicol-butyryl
CoA complex and the radioactivity was measured.
2.3. Expression and puriﬁcation of staphylococcal nuclease fusion
proteins
The (His)6-TM-SN fusion protein were expressed in BL21(DE3)
pLysS. Overnight cultures were diluted 1:100 and grown to OD600 of
2 in TBII medium before induction with 1 mM IPTG. Cells were har-
vested after induction and lysed by freeze–thaw. Proteins were ex-
tracted using buﬀer containing 25 mM Tris–HCl, pH 8, 300 mM
NaCl, and 0.3% SDS, and were puriﬁed using Ni-NTA agarose resin
(Qiagen, Valencia, CA). Protein concentration was determined by
the bicinchoninic acid protein assay (Pierce, Rockford, IL) using
bovine serum albumin as a standard.blished by Elsevier B.V. All rights reserved.
Table 1
Sequences of TMDs in the TOXCAT constructs
Name TM sequence
CD45 LIAFLAFLIIVTSIALLVVLY
PTPl IAGVIAGILLFVIIFLGVVLVM
PTPk IAGISAGILVFILLLLVVILIV
PTPq GVIAGLLMFIIILLGVMLTI
PTPk LILGICAGGLAVLILLLGAIIVII
LAR MLWVTGPVLAVILIILIVIAILLF
PTPr LIWVIGPVLAVVFIICIVIAILL
PTPd LIWVVGPVLAVVFIICIVIAILLY
PTPa IIAVMVALSSLLVIVFIIIVLYML
PTP e LLAWLLLPLLLLLLVLLLAAYFF
PTPc IIPLIVVSALTFVCLILLIAVLV
PTPf VIPLVIVSALTFICLVVLVGILI
PTPb GVSAGLFLIGMLVAVVALLI
DEP1 VICGAVFGCIFGALVIVTVGGFIFW
SAP1 VIAGAFVGILLFLILVGLLIFFL
GLEPP1 VVVISVLAILSTLLIGLLLVTLIIL
IPCPTP FYAVVIFLSIFVIIVTCLMIL
IA2 VLLTLVALAGVAGLLVALAVAL
IAb FIALTLVSLACILGVLLASGLI
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3.1. TM association of human RPTPs
We have examined the association of 19 human RPTP
TMDs in the inner membrane of E. coli using the TOXCAT
assay [9]. Sequence information was obtained from Genbank
according to the classiﬁcation of vertebrate PTPs by Andersen
et al. [13]. It has been shown that TOXCAT (and other ToxR-
based systems) is sensitive to the length of the inserted TMD
[14,15]. However, to best mimic the native RPTPs, we used
TMHMM, a Hidden Markov Model based method, to pre-
dicted the TMDs [16] and further reﬁned them based on
sequence alignment of the full length proteins (Table 1).
The level of CAT activity reﬂects the ability of a given TMD
to self-associate. Wild type glycophorin A (GpA) is known to
form a strong TM homodimer [17] and thus was used to set a
baseline for comparison. The G83I mutant of GpA is known
to weaken dimerization, and therefore was used as a calibra-
tion of weak interactions. In this system, non-interacting
TMDs give signals close to the background activity (less than
1% of GpA, data not shown), while G83I gives about 10% of
GpA activity.
All 19 TMDs showed degrees of interactions in TOXCAT,
although some cases such as PTPb are weaker being compara-
ble to the G83I mutant of GpA (Fig. 1A). The TMDs of PTPk,
DEP1 and GLEPP1 displayed comparable or higher levels of
oligomerization than GpA; CD45, LAR, PTPa, PTPc and
SAP1 gave a TOXCAT signal of more than 50% of GpA.
As a point of comparison, the TOXCAT signals for the TMDs
of ErbB receptors (a subfamily of receptor tyrosine kinases
that function as dimers) were 40–70% of GpA [18]. Similar
expression levels were found in all constructs (Fig. 1B).
DEP1 and SAP1 constructs showed slightly weaker bands,
suggesting that these TMDs may have greater homodimeriza-
tion capabilities than suggested by the data. Additionally, the
maltose binding protein (MBP) complementarity assay [9]Fig. 1. RPTP TM dimerization quantiﬁed by CAT assay. (A) CAT activities
as strong interactions (black bars). Activities lower than GpA and above 50%
than 50% GpA as weaker interactions (dotted bars). Data were obtained from
from GpA. Error bars shown are standard deviations of the four data points
monitored by western blot analysis using an antibody against the MBP domshowed that all of the TM-TOXCAT fusion proteins were in-
serted properly in the inner membrane of E. coli (data not
shown).
3.2. TM association of DEP1 mediated by speciﬁc glycines
To investigate the speciﬁcity of RPTP TM associations,
mutagenesis of the DEP1 TM-TOXCAT construct (DEP1
TM) was used. We have chosen DEP1 TM in particular both
because of its high TOXCAT signal and the presence of ﬁve
glycines in its sequence. As discussed below, glycines areinduced by TM association. Activities greater than GpA are considered
GpA are considered as moderate interactions (hatched bars), and less
two independent experiments in duplicate and normalized to the signal
from the mean. (B) Expression levels of the TOXCAT constructs were
ain.
Fig. 3. RPTP TM association in SDS. SDS–PAGE of SN–TM fusion
proteins. 8 lg/ml of proteins dissolved in the sample buﬀer containing
2% SDS were loaded in each lane, except for lane 2 where only 3 lg/ml
was loaded due to low concentration of the puriﬁed proteins.
Fig. 2. DEP1 TM association dependence upon speciﬁc glycines. (A)
Positions of the Leu or Ala mutations on DEP1 TM. (B) CAT
activities of DEP1 TM and its mutants. Activities less than 50% and
more than twofold of the wild type are shown in the dotted bars and
the black bars, respectively.
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eﬀective strategy to probe inter-helical interactions in the
TMD is to introduce steric clashes or to alter the ideal packing
by changing the size of amino acid sidechains [21]. Based on
this principle, all amino acids with small side chains (Cys,
Gly and Ala) in DEP1 TM were individually mutated to
Leu, and six amino acids with large side chains (Ile, Val,
Phe, Leu) were mutated to Ala, as shown in Fig. 2A. Com-
pared with the wild type DEP1 TM, mutations G979L,
G983L and G987L were the most disruptive (Fig. 2B). Con-
versely, the G995L and G996L mutants enhanced the activity.
The signal remained largely unchanged with other mutants
(within ±50% of the wild type activity). In all cases, proper
membrane insertion was observed and comparable expression
levels were seen (data not shown).
3.3. TM dimerization in SDS
Association in TOXCAT, while able to detect dimers, does
not eliminate the possibility of higher order oilgomers. Here,
we use SDS gels as a complementary methodology in order
to help to resolve this ambiguity [22]. SN-fusion proteins of
TMDs of seven RPTPs were expressed in E. coli and puriﬁed,
including CD45 and PTPa (to compare with available bio-
chemical data); PTPk, PTPc, DEP1 and GLEPP1 (high TOX-
CAT signal); and PTPb (low TOXCAT signal). The GpA
TMD was again used as a positive control. It is known that
the nuclease itself runs as a monomer on SDS–PAGE, and
therefore oligomers of the fusion protein that appear on the
gel are attributed to TM association in SDS micelles [22].
As shown in Fig. 3, both monomer and dimer bands are seen
on SDS–PAGE gels in most of the samples, reﬂecting an equi-
librium between monomer and dimer in SDS. The ratio of
monomer to dimer largely correlates with the stability of asso-
ciation in the membrane, except for that of DEP1 and
GLEPP1, a discrepancy we cannot fully explain. Higher order
oligomers other than dimers were observed at low concentra-
tions in the SN-DEP1 TM fusion protein with or withoutthe reducing reagent b-ME (data not shown), and so are not
due to disulﬁde linkage of cysteines in DEP1 TM.4. Discussion
The function ascribed to the TMDs of cell surface receptors
has traditionally been limited to membrane anchoring. Recent
studies, however, suggest that interactions between TM do-
mains may contribute to receptor dimerization, as seen in the
activation of the ErbB tyrosine kinase receptors [1,18], aIIb
integrin [14], and the BH3-only apoptotic proteins [23]. Thus,
there is a paradigm shift occurring regarding the importance of
the TMD, which may in fact play a speciﬁc role in receptor-
mediated signaling events in the cell. Here, we have explored
this possibility in the human RPTP family.
The importance of TMDs has been previously observed in
several RPTPs. For example, the TMD was necessary and suf-
ﬁcient for homodimerization of PTPa [7]; and the activity of
CD45 was found to be regulated by the CD45-associating pro-
tein through interaction between TMDs [24,25]. Yet, prior to
our study, it has not been clear to what extent dimerization
of TMDs might be a general theme for RPTPs. We ﬁnd that
most of the TMDs of RPTPs are able to self-interact in the
membrane.
Mutational analysis of DEP1 TM (Fig. 2) reveals that spe-
ciﬁc glycines in the TM helix are necessary for maintaining
the dimer interaction. The arrangement of three essential gly-
cines (G979, G983 and G987) resembles the well-studied
GxxxG motif (two glycines separated by any three residues)
for TM helix interaction [20]. Mutations of two other glycines
(G995 and G996), on the other hand, result in an enhancement
of TM association. One explanation is that in addition to the
GxxxGxxxG motif, residues ﬂanking the helix packing inter-
face could also contribute to TM association, as demonstrated
in a comparative study of TM interactions in GpA and bacte-
riophage M13 major coat protein [12]. Interestingly, the stron-
gest dimerization signal is from GLEPP1, which does not
3858 C.-N. Chin et al. / FEBS Letters 579 (2005) 3855–3858contain a GxxxG motif, but perhaps contains a heptad of leu-
cines, such as that identiﬁed in the TMD of the erythropoietin
receptor [15]. These observations suggest that a variety of se-
quence motifs for TM interactions may yet be identiﬁed in
the RPTP family.
The homodimerization of the CD45 and PTPa TMDs iden-
tiﬁed in this study are consistent with previous data [6–8].
Based on numerous studies on both RPTPs and RPTKs, a
rotational coupling model for receptor activation has been
proposed [3,5,26]. In this model, receptor dimers are assumed
to be stabilized by interactions between multiple structural do-
mains. Formation of functional dimers then depends upon the
relative orientation of the two monomers. Having a preferred
interaction interface could provide the TM–TM dimer with a
speciﬁc rotational position to stabilize a functional interaction.
Using mutational analysis of DEP1 TM, we have found a spe-
ciﬁc packing interface that could serve such a function.
We have surveyed the human RPTP family for TM homodi-
merization both in the membrane environment and in deter-
gent micelles. We showed that TMDs of RPTPs form dimers
in the membrane, albeit to diﬀerent extents.
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